These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 14742800)

  • 1. Vardenafil treatment for erectile dysfunction.
    Crowe SM; Streetman DS
    Ann Pharmacother; 2004 Jan; 38(1):77-85. PubMed ID: 14742800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphodiesterase 5 inhibitors for erectile dysfunction.
    Setter SM; Iltz JL; Fincham JE; Campbell RK; Baker DE
    Ann Pharmacother; 2005; 39(7-8):1286-95. PubMed ID: 15941818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erectile dysfunction: comparison of efficacy and side effects of the PDE-5 inhibitors sildenafil, vardenafil and tadalafil--review of the literature.
    Gresser U; Gleiter CH
    Eur J Med Res; 2002 Oct; 7(10):435-46. PubMed ID: 12435622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vardenafil improved patient satisfaction with erectile hardness, orgasmic function and sexual experience in men with erectile dysfunction following nerve sparing radical prostatectomy.
    Nehra A; Grantmyre J; Nadel A; Thibonnier M; Brock G
    J Urol; 2005 Jun; 173(6):2067-71. PubMed ID: 15879836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology and drug interaction effects of the phosphodiesterase 5 inhibitors: focus on alpha-blocker interactions.
    Kloner RA
    Am J Cardiol; 2005 Dec; 96(12B):42M-46M. PubMed ID: 16387566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction in patients with diabetes mellitus.
    Vickers MA; Satyanarayana R
    Int J Impot Res; 2002 Dec; 14(6):466-71. PubMed ID: 12494279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vardenafil: a review of its use in erectile dysfunction.
    Keating GM; Scott LJ
    Drugs; 2003; 63(23):2673-703. PubMed ID: 14636086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug Insight: oral phosphodiesterase type 5 inhibitors for erectile dysfunction.
    Briganti A; Salonia A; Gallina A; Saccà A; Montorsi P; Rigatti P; Montorsi F
    Nat Clin Pract Urol; 2005 May; 2(5):239-47. PubMed ID: 16474835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PDE5 inhibitors: are there differences?
    Carson CC
    Can J Urol; 2006 Feb; 13 Suppl 1():34-9. PubMed ID: 16526979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vardenafil 20-mg demonstrated superior efficacy to 10-mg in Japanese men with diabetes mellitus suffering from erectile dysfunction.
    Ishii N; Nagao K; Fujikawa K; Tachibana T; Iwamoto Y; Kamidono S
    Int J Urol; 2006 Aug; 13(8):1066-72. PubMed ID: 16903931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of vardenafil in patients with erectile dysfunction: result of a bridging study in Japan.
    Nagao K; Ishii N; Kamidono S; Osada T;
    Int J Urol; 2004 Jul; 11(7):515-24. PubMed ID: 15242361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of efficacy and safety of phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction].
    Chen Q; Wang N; Yao F; Lu X
    Zhonghua Nan Ke Xue; 2004 Apr; 10(4):302-4. PubMed ID: 15148932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo and in vitro response of corpus cavernosum to phosphodiesterase-5 inhibition in the hypercholesterolaemic rabbit.
    Firoozi F; Longhurst PA; White MD
    BJU Int; 2005 Jul; 96(1):164-8. PubMed ID: 15963142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy and safety of vardenafil for men with erectile dysfunction].
    Zhu J; Jiang H
    Zhonghua Nan Ke Xue; 2004 Sep; 10(9):704-10. PubMed ID: 15497716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erectile response to vardenafil in men with a history of nonresponse to sildenafil: a time-from-dosing descriptive analysis.
    Hatzichristou DG; Aliotta P; Auerbach S; Barkin J; Lording D; Murdock M; Wilkins HJ; McBride TA; Colopy MW; Carson CC;
    Clin Ther; 2005 Sep; 27(9):1452-61. PubMed ID: 16291418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Levitra (vardenafil)--a new PDE 5 inhibitor for the treatment of erectile dysfunction].
    Katsarov M
    Akush Ginekol (Sofiia); 2004; 43 Suppl 1():31-2. PubMed ID: 15323315
    [No Abstract]   [Full Text] [Related]  

  • 17. [Efficacy and safety of vardenafil in difficult-to-treat erectile dysfunction men].
    Wang CH
    Zhonghua Nan Ke Xue; 2006 Apr; 12(4):377-80. PubMed ID: 16683577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vardenafil improves erectile function in men with erectile dysfunction irrespective of disease severity and disease classification.
    Donatucci C; Eardley I; Buvat J; Gittelman M; Kell P; Segerson T; Homering M; Montorsi F;
    J Sex Med; 2004 Nov; 1(3):301-9. PubMed ID: 16422960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vardenafil preclinical trial data: potency, pharmacodynamics, pharmacokinetics, and adverse events.
    Bischoff E
    Int J Impot Res; 2004 Jun; 16 Suppl 1():S34-7. PubMed ID: 15224134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology of phosphodiesterase-5 inhibitors.
    Corbin JD; Francis SH
    Int J Clin Pract; 2002; 56(6):453-9. PubMed ID: 12166544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.